Sanofi Diabetes

Welcome to Sanofi Diabetes

Living with Diabetes can be challenging, but by managing your condition with some support, you can live well. On this website you can find many resources and support to better understand the basics on how to live and stay well with diabetes and how to have a positive start and experience with the medication that’s prescribed to you.

Toujeo® DoubleStar

(insulin glargine 300 units/mL)

Toujeo DoubleStar Pen

More

Toujeo® SoloStar®

(insulin glargine 300 units/mL)

Toujeo SoloStar Pen

More

Lantus® SoloStar®

(insulin glargine 100 units/mL)

Lantus SoloStar Pen

More

Suliqua® SoloStar® 100/33

(insulin glargine (100 units/ml) and lixisenatide)

Suliqua SoloStar 100/33 Pen

More

Suliqua® SoloStar® 100/50

(insulin glargine (100 units/ml) and lixisenatide)

Suliqua SoloStar 100/50 Pen

More

Admelog®

(insulin lispro 100 units/mL)

Admelog Pen

More

Trurapi®

(insulin aspart (100 units/mL)

Trurapi Pen

More

Adverse events should be reported
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to the Sanofi drug safety department on 0800 0902 314.
Alternatively, send via email to UK-drugsafety@sanofi.com

This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

MAT-GB-2101528 (v5.0)
Date of Preparation: October 2022